CORC

在结果中检索

CORC

浏览/检索结果: 共12条，第1-10条 帮助

限定条件                
已选(0)清除 条数/页：   排序方式：
Does EGFR Mutation Type Influence Patient-Reported Outcomes in Patients with Advanced EGFR Mutation-Positive Non-Small-Cell Lung Cancer? Analysis of Two Large, Phase III Studies Comparing Afatinib with Chemotherapy (LUX-Lung 3 and LUX-Lung 6) 期刊论文
The Patient - Patient-Centered Outcomes Research, 2018, 卷号: 11, 期号: 1, 页码: 131-141
作者:  Wu, Yi-Long;  Hirsh, Vera;  Sequist, Lecia V.;  Hu, Cheng-Ping;  Feng, Jifeng
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/03
China experts consensus on the diagnosis and treatment of advanced stage primary lung cancer (2016 version) 期刊论文
Asia‐Pacific Journal of Clinical Oncology, 2017, 卷号: 13, 期号: 1, 页码: 87-103
作者:  Shi, Yuankai*;  Sun, Yan;  Yu, Jinming;  Ding, Cuimin;  Wang, Ziping
收藏  |  浏览/下载：8/0  |  提交时间：2019/12/03
EGFR mutation detection in circulating cell-free DNA of lung adenocarcinoma patients: analysis of LUX-Lung 3 and 6 期刊论文
British Journal of Cancer, 2017, 卷号: 116, 期号: 2, 页码: 175-185
作者:  Wu, Yi-Long*;  Sequist, Lecia V;  Hu, Cheng-Ping;  Feng, Jifeng;  Lu, Shun
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/03
Icotinib versus whole-brain irradiation in patients with EGFR-mutant non-small-cell lung cancer and multiple brain metastases (BRAIN): a multicentre, phase 3, open-label, parallel, randomised controlled trial 期刊论文
The Lancet Respiratory Medicine, 2017, 卷号: 5, 期号: 9, 页码: 707-716
作者:  Yang, Jin-Ji;  Zhou, Caicun;  Huang, Yisheng;  Feng, Jifeng;  Lu, Sun
收藏  |  浏览/下载：9/0  |  提交时间：2019/12/03
Randomized phase III trial of amrubicin/cisplatin versus etoposide/cisplatin as first-line treatment for extensive small-cell lung cancer 期刊论文
BMC Cancer, 2016, 卷号: 16, 期号: 1, 页码: 265
作者:  Sun, Yan*;  Cheng, Ying;  Hao, Xuezhi;  Wang, Jie;  Hu, Chengping
收藏  |  浏览/下载：6/0  |  提交时间：2019/12/03
Platinum‐based chemotherapy plus cetuximab first‐line for Asian patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: Results of an open‐label, single‐arm, multicenter trial 期刊论文
Head & Neck, 2015, 卷号: 37, 期号: 8, 页码: 1081-1087
作者:  Guo, Ye;  Shi, Mei;  Yang, Ankui;  Feng, Jifeng;  Zhu, Xiaodong
收藏  |  浏览/下载：9/0  |  提交时间：2019/12/03
Symptom and Quality of Life Improvement in LUX-Lung 6: An Open-Label Phase III Study of Afatinib Versus Cisplatin/Gemcitabine in Asian Patients With EGFR Mutation-Positive Advanced Non-small-cell Lung Cancer. 期刊论文
Journal of Thoracic Oncology, 2015, 卷号: 10, 期号: 6, 页码: 883-889
作者:  Geater, Sarayut L;  Xu, Chong-Rui;  Zhou, Caicun;  Hu, Cheng-Ping;  Feng, Jifeng
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/03
Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials 期刊论文
The Lancet Oncology, 2015, 卷号: 16, 期号: 2, 页码: 141-151
作者:  Yang, James Chih-Hsin*;  Wu, Yi-Long;  Schuler, Martin;  Sebastian, Martin;  Popat, Sanjay
收藏  |  浏览/下载：5/0  |  提交时间：2019/12/03
BEYOND: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase III Study of First-Line Carboplatin/Paclitaxel Plus Bevacizumab or Placebo in Chinese Patients With Advanced or Recurrent Nonsquamous Non-Small-Cell Lung Cancer. 期刊论文
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015, 卷号: 33, 期号: 19, 页码: 2197-U108
作者:  Zhou, Caicun*;  Wu, Yi-Long;  Chen, Gongyan;  Liu, Xiaoqing;  Zhu, Yunzhong
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/03
Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial 期刊论文
The Lancet Oncology, 2014, 卷号: 15, 期号: 2, 页码: 213-222
作者:  Wu, Yi-Long*;  Zhou, Caicun;  Hu, Cheng-Ping;  Feng, Jifeng;  Lu, Shun
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/03

©版权所有 ©2017 CSpace - Powered by CSpace